Why Real Estate Professionals Should Know (and care) About The New Corporate Transparency Act
Read More
Matthew advises public and private companies at every stage of the corporate life cycle. With his broad background in corporate and securities law, Matthew helps clients grow their businesses from start-up, through growth funding, ongoing operations and exit planning.
Matthew’s practice also includes advising companies on mergers and acquisitions, contracts, lending, work-outs, corporate governance matters. He also advises nonprofit organizations in a variety of matters including governance, lifecycle, merger, dissolution.
Matthew helped to write several of Connecticut’s business entity laws, including the new Uniform Limited Liability Company Act and the Connecticut Entity Transactions Act. He was also the associate reporter for the American Bar Association’s Model Nonprofit Corporation Act drafting committee, which recently published the Fourth edition of the Model Act.
Society for Governance Professionals
Chair, Business Law Section of the Connecticut Bar Association, 2024-present
New Haven County Bar Association
American Bar Association, Business Law Section
ABA Model Nonprofit Corporation Act Drafting Committee
New Leader in the Law, Connecticut Law Tribune, 2015
Rising Star, New England Super Lawyers® – Business/Corporate, 2014, 2016-17
Rising Star, Connecticut Super Lawyers® – Business/Corporate, 2013-2017
Advised Australia-based international start-up, CH4 Global, a pioneer in utilizing seaweed to drastically reduce ruminant methane emissions, on its $13 million Series A funding led by DCVC, the Silicon Valley venture capital fund.
Advised medical device company on exclusive license to commercialize technology developed at a university.
Advised radar technology company Xandar Kardian Inc., with operations in Korea and Canada, on $12 million Series a funding led by a consortium of venture capital funds.
Advised a New Haven based health technology company founded in 2015 that puts patients in charge of their health information, on its $4 million convertible note bridge financing.
Advised drone company on $9 million funding from a family office investor.
Advised multiple startups on angel, convertible and SAFE financings.
Represented Upward Labs, a Hartford-based accelerator, in formation and operations over multiple cohorts.
Advised aerospace manufacturer in $36 million sale to venture-backed platform company.
Represented 4th generation manufacturing company with international operations in $315 million sale to publicly traded acquirer.
Advised private equity fund in acquisition of electronics distributor.
Advised private equity fund in platform acquisition of food manufacturer.
Represented private equity company in acquisition of platform pest control equipment company, international bolt-on acquisitions, and eventual sale to strategic acquirer.
Advised on the acquisition and disposition of precision medical device components company.
Carmody represented a New York real estate developer on a matter involving commercial refinance, business equity line and buyout of business partners.
Carmody was lead counsel in restructuring ownership of a United States based company providing investigative services in all 50 states to domestic insurance companies and the simultaneous closing of the acquisition of a competitor.
Advised public charity on dissolution and disposition of endowment, including cy pres.
Counsel to charitable entity organized as LLC in restructuring to assure compliance with exempt entity guidance.
Carmody provides subsidiary management services for hundreds of domestic and international subsidiaries of publicly traded companies. Carmody also regularly serves as U.S. legal counsel on cross-border intercompany reorganizations.